STAAR Surgical Company（STAA）今日盘前股价大幅上涨21.84%，引起了市场的广泛关注。
消息面上，Canaccord Genuity将STAAR Surgical的股票评级从“持有”上调至“买入”，同时将其目标价从22美元上调至27美元。分析师评级和目标价的上调，通常反映了机构对公司未来业绩和增长潜力的乐观预期，这直接提振了市场信心，推动了股价在盘前时段的强劲上涨。
此次评级调整是华尔街证券分析师当日发布的众多研究报告之一，凸显了机构对STAAR Surgical在医疗设备领域前景的看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.